Adthyza
Pricing Report NDC 24338-065-90

View Wholesale Price per Unit, Acquisition Costs, and Historic Pricing Trends
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Adthyza Thyroid (NDC 24338-065-90) is $0.81267 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 20, 2025.

As a provided by Azurity Pharmaceuticals, Inc., this medication is distributed in a 90 TABLET in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.81267
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 20, 2025
Billable Units
90 EA
Estimated Package Price
$73.14
Data Status
As of Jul 08, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
B - Brand
Package NDC
24338-065-90
Description
90 TABLET in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was carried forward from the previous file.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2024, the NADAC wholesale price for (NDC ) has moved within a range of $0.61465 to $0.81267 per EA. Over this 1 year and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.6147 - $0.8127
Market Volatility
32.22% Variance
Latest Trend
No Change
Date Unit Price Unit Source Method Rate
Aug 20, 2025 $0.81267 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 20, 2025 $0.81267 EAC/I - Chain or Independent PharmacyCode 4, 6B - Brand
Jul 23, 2025 $0.81267 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 18, 2025 $0.81163 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 21, 2025 $0.81163 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 23, 2025 $0.65717 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 19, 2025 $0.63720 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Feb 19, 2025 $0.63720 EAC/I - Chain or Independent PharmacyCode 2, 6B - Brand
Jan 22, 2025 $0.63498 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Dec 18, 2024 $0.63498 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Nov 20, 2024 $0.63073 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Oct 23, 2024 $0.61783 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Sep 18, 2024 $0.62638 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Aug 21, 2024 $0.61465 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jul 17, 2024 $0.61465 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Jun 19, 2024 $0.63058 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
May 22, 2024 $0.63058 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand
Apr 17, 2024 $0.63992 EAC/I - Chain or Independent PharmacyCode 1, 6B - Brand

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 2: The average acquisition cost of the most recent survey was within ± 2% of the current NADAC; therefore, the NADAC was carried forward from the previous file.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: July 08, 2026